(Apply through ESA website)
ESA Early Career Publication Grant
Application Closing date: 9 August 2024
Conditions of award
The purpose of this award is to provide funding to support early stage research or small research projects by a mid-career ESA member. These grants may be used for research in any area of endocrinology. The research must be conducted in Australia.
Seed Grants are valued at $10,000.
Eligibility
Application
Applications are to be submitted online. Applications must include:
All documents to be uploaded in word (.doc or .docx) or PDF format.
Selection
Applications are assessed by a Selection Committee selected by ESA Council. The selection committee has a duty to apply the criteria equitably to all applicants.
Applicants will be assessed on:
Applications involving ENSA (Endocrine Nurses Society of Australasia) are encouraged.
Administration of the Seed Grant
The award recipient must be undertaking work within a hospital, university department, research institute or other approved institute within Australia. The financial administration of the award will be through the appropriate finance office of the institution.
Report
At the conclusion of the award, the recipient must submit their research findings for presentation at the Endocrine Society of Australia annual scientific meeting.
Twelve months after commencement of the seed grant tenure, a research report for inclusion into the ESA annual report must be submitted to the ESA council for review via email addressed to the ESA. Secretariat: ijohnson@endocrinesociety.org.au
Publications
Any publication(s) (papers or conference abstracts) derived from the project must acknowledge the financial support of the Endocrine Society of Australia.
Submit your ESA Research Seed Grants application online.
Application Closing date: 31 December 2024
Conditions of award
The purpose of this grant is to support publication of a high impact endocrinology-focussed scientific article by an ESA early career member through reimbursement of publication costs.
Publication Grants are valued up to $3,000. Up to two grants will be awarded annually, one to a clinical member and one to a basic science member.
Recipients will be asked to write a short summary of their research to contribute to ESA communications.
Applicants can apply for both this award and the Young Investigator Scientific Article Award for the same publication, but can only receive one award.
Eligibility
Application
Applications are to be submitted online.
Applications must include:
Selection
Applications are assessed by a Selection Committee selected by ESA Council.
Applicants will be assessed primarily on the quality of the article and secondly on the quality of the journal. The applicant’s track record will also be taken into account, particularly in instances where there are applications of otherwise similar quality.
Publication Grants will be awarded at the sole discretion of ESA Council. It is anticipated that successful applications will be for articles published in journals with an impact factor of at least 3 and/or a Scientific Journal Ranking of Q1 or Q2 (see https://www.scimagojr.com/journalrank.php).
A commemorative plaque will be presented at the dinner associated with the AGM. The awardee will receive free registration to the ASM.
Submission
Submit your ESA Early Career Publication Grant application online.
Application deadline: This award is no longer being offered.
The purpose of this award is to support a project in the area of either male hypogonadism OR diabetes insipidus.
One award of $15,000 will be made, funded by an unrestricted grant from Ferring to the Endocrine Society of Australia.
A final report will be required by ESA and Ferring within 6 months of completion. The report must be emailed to the ESA Secretariat ijohnson@endocrinesociety.org.au.
At the conclusion of the award, the recipient must submit their research findings for presentation at the Endocrine Society of Australia annual scientific meeting.
This award will provide funding to an individual who has developed special clinical skills in Endocrinology, to encourage innovation and clinical excellence in the area of male hypogonadism or diabetes insipidus.
The funds must be used improve a specific Endocrine service, by way of a clinical quality use of medicine or research project related to management of male hypogonadism or diabetes insipidus. The research shall be undertaken in an Australian facility that provides salary support and infrastructure to support the awardee achieve that goal.
Priority will be given to applications where the proposed improvement may lead to a model that could be transferable to other Endocrine services.
While the award money may or may not involve a scientific research component, clear goals of how the clinician will utilise the grant should be provided and metrics around the initiative should be collected and disseminated (e.g., ESA abstract submission).
The Applicant must:
The Sponsoring Institution must:
Applications are to be submitted online. These must include:
All documents to be uploaded in word (.doc or .docx) or PDF format.
Applications are assessed by a Selection Committee selected by ESA Council.
Applicants will be assessed on:
The project must not involve research that generates outcomes specifically related to, or stipulates/promotes the use of, any Ferring medicinal product.
Preference will be given to applicants who have not previously received this award.
The award recipient must be undertaking work within a hospital, university department, research institute or other approved institute. The financial administration of the award will be through the appropriate finance office of the institution.
Any grant funds that are awarded must not be used for overhead or operational expenses such as salary support or day to day running costs of a medical institution.
At the conclusion of the award, the recipient must submit their research findings for presentation at the Endocrine Society of Australia annual scientific meeting.
Any publications (papers or conference abstracts) derived from the project must acknowledge and financial support of the Endocrine Society of Australia and disclose the award funding from Ferring.